In 2019, Siemens Healthineers bought out Corindus for $1.1 billion. Corindus develops the CorPath robot-assisted device for coronary and peripheral vascular procedures.
According to a news release, brand unification represents “the final step” in the company integration process that began in 2019. The business aims to advance interventions with robotics, changing the delivery of care through innovations. These innovations enhance physician techniques and bring precision to interventional procedures, Siemens said.
Siemens said it now offers the Endovascular Robotics business access to its company-wide resources. That allows it to continue advancing its vision of developing innovative, image-guided robotic solutions. It intends to continue…